Literature DB >> 3673517

Cell kinetics of the malignant evolution of meningothelial meningioma.

T Iwaki1, I Takeshita, M Fukui, K Kitamura.   

Abstract

A meningotheliomatous meningioma occurred in the right parietal parasagittal region of a 43-year-old woman. A total excision was carried out. Three years and 9 months later, one parasagittal and two falx tumors in close proximity recurred and were excised. The falx tumors showed the features of an anaplastic transitional meningioma with increased mitoses. The falx meningioma recurred locally and repeatedly, despite radiation therapy and chemoimmunotherapy. She died 7 years and 8 months after the onset. At autopsy, the tumor was found to have metastasized via the cerebrospinal fluid to the spinal cord and pituitary stalk. Extracranial metastases were not evident. At the fourth craniotomy, bromodeoxyuridine (BrdU) was administered intravenously to label tumor cells in the S phase of the cell cycle. The BrdU-labeled cells accounted for 9.0%; they are usually less than 1% in benign meningiomas. Meningothelial meningiomas with a high labeling index recur rapidly, even after Simpson's grade 2 removal, and treatment for a malignant meningioma should be instituted.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3673517     DOI: 10.1007/bf00688188

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  18 in total

1.  The recurrence of intracranial meningiomas after surgical treatment.

Authors:  D SIMPSON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1957-02       Impact factor: 10.154

2.  The prognosis in meningiomas.

Authors:  K Skullerud; A C Löken
Journal:  Acta Neuropathol       Date:  1974       Impact factor: 17.088

3.  Histological subtypes and prognostic problems in meningiomas.

Authors:  K Jellinger; F Slowik
Journal:  J Neurol       Date:  1975       Impact factor: 4.849

4.  Irradiation of meningioma: a prototype circumscribed tumor for planning high-dose irradiation of the brain.

Authors:  M Friedman
Journal:  Int J Radiat Oncol Biol Phys       Date:  1977 Sep-Oct       Impact factor: 7.038

5.  The problem of malignancy in meningiomas.

Authors:  J S Tytus; J T Lasersohn; E Reifel
Journal:  J Neurosurg       Date:  1967-12       Impact factor: 5.115

6.  Radiotherapy in the management of meningiomas.

Authors:  D L King; C H Chang; J L Pool
Journal:  Acta Radiol Ther Phys Biol       Date:  1966

7.  Papillary meningioma: a malignant variant of meningioma.

Authors:  S K Ludwin; L J Rubinstein; D S Russell
Journal:  Cancer       Date:  1975-10       Impact factor: 6.860

8.  Role of radiation therapy in the management of meningioma.

Authors:  R J Carella; J Ransohoff; J Newall
Journal:  Neurosurgery       Date:  1982-03       Impact factor: 4.654

9.  Recurrence of intracranial meningiomas, with special reference to radiotherapy.

Authors:  J Yamashita; H Handa; K Iwaki; M Abe
Journal:  Surg Neurol       Date:  1980-07

10.  Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: A new reagent for detection of DNA replication.

Authors:  H G Gratzner
Journal:  Science       Date:  1982-10-29       Impact factor: 47.728

View more
  5 in total

1.  Bromodeoxyuridine labeling study of intracranial meningiomas: proliferative potential and recurrence.

Authors:  K S Lee; T Hoshino; L A Rodriguez; J Bederson; R L Davis; C B Wilson
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

2.  Metastasis in meningioma.

Authors:  S A Enam; S Abdulrauf; B Mehta; G M Malik; A Mahmood
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

Review 3.  The application of 5-bromodeoxyuridine in the management of CNS tumors.

Authors:  A Freese; D O'Rourke; K Judy; M J O'Connor
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

4.  Radiation-induced meningiomas and their proliferative activity. Cytokinetic study using bromodeoxyuridine.

Authors:  T Tashima; M Fukui; S Nishio; K Fujii; T Iwaki
Journal:  Acta Neurochir (Wien)       Date:  1990       Impact factor: 2.216

5.  An immunohistochemical study of tissue transglutaminase in gliomas with reference to their cell dying processes.

Authors:  T Iwaki; M Miyazono; T Hitosumatsu; J Tateishi
Journal:  Am J Pathol       Date:  1994-10       Impact factor: 4.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.